Journal profile · Oncology
Acta Oncologica
ISSN 0284-186X · eISSN 1651-226X · Informa Healthcare · NORWAY · Bimonthly · Founded 1987
Acta Oncologica: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.71; fully open access; median 73 days to acceptance (107 articles, last 24 months); community-reported acceptance: about 50%; 208 articles in 2025; indexed in SCIE and Scopus.
The latest issue on the journal's website is from 2023 (Volume 62, Issue 12): the journal may have stopped publishing or moved platform in the last two years. Check its website before submitting.
Scope
Aims, scope and focus
Acta Oncologica is published by Informa Healthcare and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Radiotherapy Techniques, Cancer survivorship and care and Breast Cancer Treatment Studies, together about 25.2% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Aims and scopeJournal metrics Published by Medical Journals Sweden from 2024. Acta Oncologica is an international peer-reviewed journal based in the Nordic countries. The journal welcomes international contributions and offers global reach. Acta Oncologic a provides the scientific community with a platform for innovative, comprehensive and clinically relevant cancer research. We strive to publish impactful cancer research with potential to influence future oncology and aim to advance high-quality, clinically relevant cancer research across the broad field of oncology. Acta Oncologica is owned by the non-for-profit Acta Oncologica Foundation and is the official scientific journal for the Nordic National Oncology Societies and the Nordic Association of Clinical Physics (NACP). Acta Oncologica provides a forum for the exchange of information on the etiology, prevention, diagnosis and treatment of all cancer types. The journal welcomes articles in the following emerging areas: Cancer epidemiology Cancer diagnostics, biomarkers and precision medicine Medical oncology, radiotherapy and radiophysics Survivorship, rehabilitation, late side effects and palliative care Clinical trial protocols (in letter format) Acta Oncologica publishes original research articles, review articles, letters/brief communications and editorial comments. Acta Oncologica’s editorial team is committed to efficient, rigorous and constructive peer-review and fair evaluations. The journal operates a single-anonymized peer review policy. Read full aims and scope
From the journal's Aims & Scope
Research area (LetPub): Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Radiotherapy TechniquesPhysics and Astronomy12.1%
- Cancer survivorship and careMedicine6.6%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology6.5%
- Radiation Therapy and DosimetryMedicine5.9%
- Head and Neck Cancer StudiesMedicine5.6%
- Prostate Cancer Diagnosis and TreatmentMedicine4.6%
- Lung Cancer Diagnosis and TreatmentMedicine4.4%
- Lung Cancer Treatments and MutationsMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.71LetPub ·
- CiteScore 2026-06
- 3.9LetPub ·
- SJR 2026-06
- 0.95LetPub ·
- SNIP 2026-06
- 0.91LetPub ·
- h-index
- 88LetPub ·
- h-index
- 152OpenAlex ·
- i10-index
- 4,372OpenAlex ·
- 2-year mean citedness
- 2.75OpenAlex ·
- Self-citation rate
- 11.1%LetPub ·
- Share of gold OA articles
- 99.62%LetPub ·
Volume
- Articles per year
- 196LetPub ·
- Articles per year (publisher)
- 92,991Publisher website ·
Articles by year OpenAlex count · 7,566 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 103 | 103 | 49 |
| 2025 | 208 | 208 | 492 |
| 2024 | 131 | 131 | 673 |
| 2023 | 270 | 270 | 1,826 |
| 2022 | 171 | 171 | 1,284 |
| 2021 | 235 | 235 | 3,420 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
73 daysMedian, submission to acceptance · P25–P75 57 days – 103 days
- Acceptance to online
- median 21 days (107 articles)
- Submission to online
- median 99 days
- Sample
- 107 articles with submission and acceptance dates (341 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Overview Open journals Open Select Dove Medical Press F1000Research
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- NORWAY
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1987
- ISSN
- 0284-186X
- Electronic ISSN
- 1651-226X
- Latest issue on the website
- Volume 62, Issue 12 (2023)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Acta Oncologica
What CAS zone is Acta Oncologica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Acta Oncologica is in Zone 3 of Medicine, and in Zone 3 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Acta Oncologica?
The latest impact factor listed by LetPub is 2.71; CiteScore 3.9, h-index 152.
How long does peer review take at Acta Oncologica?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 73 days (interquartile range 57–103 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Acta Oncologica?
According to LetPub and DOAJ records, Acta Oncologica is indexed in SCIE, Scopus and DOAJ.
Is Acta Oncologica open access, and what is the APC?
Acta Oncologica is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .